Clinical significance of BRAF mutations in metastatic melanoma
Forty to eighty percent of melanoma tumors have activating mutations in BRAF although the clinical importance of these mutations is not clear. We previously reported an analysis of BRAF mutations in metastatic melanoma samples from 68 patients. In this study, we correlated patient baseline character...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2004
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544849/ |